Affluent Medical SA Overview
Pro stress-test →Affluent Medical is a French MedTech company specialising in the international development and industrialisation of innovative clinical-stage medical prostheses for the treatment of urinary incontinence and mitral valve pathology. The company develops innovative, next-generation, minimally invasive implants to restore critical physiological functions in cardiovascular and urological therapies.
Strategic Profile
Pro stress-test →Founded by Truffle Capital, Affluent Medical aims to become a global benchmark player in the field of urology and interventional cardiology. The company recently became Carvolix and announced the finalisation of acquisitions of Caranx Medical and Artedrone, signaling a shift toward strategic consolidation to build comprehensive treatment portfolios.
Competitive Landscape
Pro stress-test →The MedTech medtech device market for mitral valve and urinary incontinence solutions is dominated by established players like Edwards Lifesciences (Sapien), Abbott (MitraClip), and Boston Scientific. Affluent Medical competes as an innovative disruptor with minimally invasive approaches but lacks the commercial scale and regulatory approval of incumbents.
Industry Context
Affluent Medical SA operates in Medical Device Manufacturing - Minimally Invasive Implants & Prostheses.
Key facts
Founded: 2011 · Headquarters: Aix-en-Provence, France · Employees: 77 · Market cap: $47.4M